Announcement on Convening Performance Briefing for 2025 and Q1 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Convening Performance Briefing for 2025 and Q1 2026
Filed with SSE · · 3 pages · Chinese
Release
Shanghai Xiao Fang Pharmaceutical Co., Ltd. on 6ix
Earlier from Shanghai Xiao Fang Pharmaceutical
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Completing Industrial and Commercial Change Registration
- Report for Q1 2026
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Notice on Convening the 1st Extraordinary General Meeting in 2026
Later from Shanghai Xiao Fang Pharmaceutical
- Announcement on Lifting Sales Restrictions and Listing for Circulation in the 1st Restriction Lifting Period for the 1st Grant under 2025 Restricted Stock Incentive Plan
- Announcement on Resolutions of the 11th Meeting of the 2nd Board of Directors
- Announcement on Redemption of Partial Temporarily Idle Raised Funds Used for Cash Management
- Publicity Explanation and Verification Opinions of the Remuneration and Appraisal Committee of the Board of Directors on List of Initially Granted Incentive Objects in the 2026 Restricted Stock Incentive Plan
- Announcement on Implementation of Dividend Distribution for 2025
Follow Shanghai Xiao Fang Pharmaceutical into a list and get an email when it puts out news.
Follow Shanghai Xiao Fang Pharmaceutical